HPLC purity
Reverse-phase HPLC with UV detection; purity target reported per lot with related-substance reporting on request.
TB FragHPLC ≥ 99%MS confirmed2mg
Vial illustrations reflect supplied lyophilized format. Distribution scope and destination market confirmed before invoicing.
| Compound | TB Frag (Ac-SDKP) |
|---|---|
| CAS number | 120081-14-3 |
| Molecular formula | C20H33N5O9 |
| Molecular weight | 487.5 g/mol |
| Sequence | Ac-SDKP (Ac-Ser-Asp-Lys-Pro) |
| Form | Lyophilized powder, glass vial |
| Purity target | ≥ 99% by HPLC |
| Vial formats | 2mg / 5mg / 10mg |
| Documentation | Batch-linked COA + HPLC chromatogram + MS identity record for every production lot |
| Distribution scope | Research use, worldwide |
| Storage | Store lyophilized powder at -20°C, protected from light and moisture; short-term ambient transit is tolerated. After reconstitution, keep at 2-8°C and use within a research-defined window. |
MOQ & lead time
| Tier | Quantity | Lead time |
|---|---|---|
| OEM lot | 50 kits (500 vials) | 3–7 days |
| Production lot | 500–1,000 vials | 10–14 days |
| OEM repeat | 1,000+ vials | 14–18 days, scheduled |
Supplied as a research-use peptide. Every quote confirms current-batch COA, purity, destination market and buyer track before invoicing.
Overview
About TB Frag (Ac-SDKP).
TB Frag (Ac-SDKP) is a naturally occurring tetrapeptide bioregulator cleaved from the N-terminus of thymosin β4. In published preclinical research it has been studied for anti-fibrotic, pro-angiogenic and hematopoietic-regulatory activity, associated in part with the ACE/Ac-SDKP axis and inhibition of prolyl oligopeptidase; it is chemically and functionally distinct from the thymosin β4 17-23 fragment (TB-500).
Documentation
Batch documentation support for TB Frag (Ac-SDKP) lots.
batch-linked COA, HPLC chromatogram and MS identity record for every production lot. Distribution scope confirmed before invoicing.
MS identity
Mass spectrometry identity confirmation against the TB Frag (Ac-SDKP) reference profile.
Lot traceability
Compound prefix and lot serial printed on the vial label and repeated in the document pack and carton.
FAQ
TB Frag (Ac-SDKP) — frequently asked by B2B buyers.
What exactly is TB Frag, and how is it different from TB-500?
TB Frag is the N-terminal fragment (residues 1-4) of thymosin β4, sequence Ac-Ser-Asp-Lys-Pro (Ac-SDKP / Goralatide). It is a different molecule from TB-500, which is the acetylated 17-23 actin-binding fragment (Ac-LKKTETQ). We list both as separate SKUs so buyers order the intended peptide.
What documentation ships with each lot?
Each lot ships with a Certificate of Analysis including an HPLC purity chromatogram and mass-spec confirmation against the expected molecular weight (~487.5 g/mol, formula C20H33N5O9). Additional third-party or independent lab verification can be arranged on request.
What vial sizes and minimum order quantity are available?
Standard formats are 2 mg, 5 mg and 10 mg lyophilized vials, with a minimum order of 50 kits (500 vials). Fill weights, bulk powder quantities and custom vialing are available for private-label and OEM programs.
How is the material supplied and shipped?
It is supplied as a lyophilized (freeze-dried) white powder in sealed vials. We offer cold-chain and ambient shipping options and can advise on packaging for international freight; buyers specify the destination and preferred incoterms at RFQ.
Is this material sold for consumer or medical use?
No. It is offered strictly as a research-use raw material and OEM input; we make no consumer, therapeutic or dosing claims. The buyer is responsible for regulatory classification, labeling and import compliance in the destination market. Custom private-label labeling is available.
Related compounds